AJP - Regu Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R243-R252, 2005. First published September 2, 2004; doi:10.1152/ajpregu.00324.2004
0363-6119/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/R243    most recent
00324.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dombkowski, R. A.
Right arrow Articles by Olson, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dombkowski, R. A.
Right arrow Articles by Olson, K. R.

COMPARATIVE AND EVOLUTIONARY PHYSIOLOGY

Vertebrate phylogeny of hydrogen sulfide vasoactivity

Ryan A. Dombkowski,1,2 Michael J. Russell,1 Alexis A. Schulman,1 Meredith M. Doellman,2 and Kenneth R. Olson1,2

1South Bend Center for Medical Education, Indiana University School of Medicine, University of Notre Dame, and 2Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana

Submitted 17 May 2004 ; accepted in final form 26 August 2004


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Hydrogen sulfide (H2S) is a recently identified endogenous vasodilator in mammals. In steelhead/rainbow trout (Oncorhynchus mykiss, Osteichthyes), H2S produces both dose-dependent dilation and a unique dose-dependent constriction. In this study, we examined H2S vasoactivity in all vertebrate classes to determine whether H2S is universally vasoactive and to identify phylogenetic and/or environmental trends. H2S was generated from NaHS and examined in unstimulated and precontracted systemic and, when applicable, pulmonary arteries (PA) from Pacific hagfish (Eptatretus stouti, Agnatha), sea lamprey (Petromyzon marinus, Agnatha), sandbar shark (Carcharhinus milberti, Chondrichthyes), marine toad (Bufo marinus, Amphibia), American alligator (Alligator mississippiensis, Reptilia), Pekin duck (Anas platyrhynchos domesticus, Aves), and white rat (Rattus rattus, Mammalia). In otherwise unstimulated vessels, NaHS produced 1) a dose-dependent relaxation in Pacific hagfish dorsal aorta; 2) a dose-dependent contraction in sea lamprey dorsal aorta, marine toad aorta, alligator aorta and PA, duck aorta, and rat thoracic aorta; 3) a threshold relaxation in shark ventral aorta, dorsal aorta, and afferent branchial artery; and 4) a multiphasic contraction-relaxation-contraction in the marine toad PA, duck PA, and rat PA. Precontraction of these vessels with another agonist did not affect the general pattern of NaHS vasoactivity with the exception of the rat aorta, where relaxation was now dominant. These results show that H2S is a phylogenetically ancient and versatile vasoregulatory molecule that appears to have been opportunistically engaged to suit both organ-specific and species-specific homeostatic requirements.

cardiovascular; fish; amphibian; reptile; bird; mammal; evolution


HYDROGEN SULFIDE (H2S) is found in both aquatic and terrestrial environments where it can be produced by both natural and industrial processes (15). Long known for its toxic properties (15, 25, 31), H2S has recently been found to be synthesized by, and have physiological actions on, a variety of mammalian tissues, including brain (1), vascular (16, 45), gastrointestinal (16, 38), reproductive (34, 38), pulmonary (33, 44), and heart (14). H2S has recently been proposed to be an endogenous gasotransmitter (41) similar to two other vasoactive gases, nitric oxide (NO; Ref. 13) and carbon monoxide (21).

The importance of H2S in the mammalian cardiovascular system is well documented. H2S produces a dose-dependent relaxation of rat arteries and veins in vitro, and it lowers blood pressure in these animals in vivo (47). In vascular smooth muscle cells, H2S is synthesized by the pyridoxal-5'-dependent enzyme, cystathionine {gamma}-lyase (47), and circulating plasma levels are sufficiently high to produce vasoactive effects (44, 47). The pathway(s) through which H2S exerts its dilatory activity has not been completely established, although it is evident that potassium channels, especially those sensitive to ATP (K), are involved, and, when opened by H2S, the resulting hyperpolarization initiates relaxation (45, 47).

In some instances, H2S appears to interact with NO, thereby augmenting relaxation in rat thoracic aorta and portal veins in vitro (16). Blockade of NO synthase via nitro-L-arginine methyl ester (L-NAME) also reduces the relaxation efficacy of NaHS (45). Similar synergy has been demonstrated in vivo. L-NAME-induced-hypertensive rats display decreased mRNA transcription of cystathionine {gamma}-lyase and lower plasma H2S levels, and, although exogenous H2S is able to counteract the hypertensive effects of L-NAME treatment, it does not alter NO production (48). Pretreatment of rat aorta with low concentrations of sodium nitroprusside (SNP) does not significantly affect NaHS-induced relaxation; however, low-dose NaHS significantly reduces SNP-induced vasorelaxation, suggesting that NO likely stimulates the H2S pathway, whereas the opposite does not appear to be the case. It is evident that the relationship between these two gases affords an additional level of cardiovascular integration.

If H2S is a physiologically relevant vasoregulatory molecule, it is likely to display a long phylogenetic history. Recent work in our laboratory has indicated that H2S may also be an important vasoregulatory signal in trout (7). However, unlike that observed in mammals, H2S produces a triphasic relaxation-contraction-relaxation in isolated conductance arteries (efferent branchial artery and celiacomesenteric artery) and veins (anterior cardinal vein) from steelhead trout (Oncorhynchus mykiss, Skamania strain). Although phase 1 relaxation is relatively minor, phase 2 contraction and phase 3 relaxation are quite pronounced. Both phase 2 and phase 3 are dose-dependent, with EC50 values of 1.1 x 10–3 M and 6.7 x 10–5 M, respectively; the apposition of the phase 3 EC50 with plasma titers of H2S (4.0 x 10–5 M) in trout indicates that this gas may be tonically vasoactive (7).

A H2S-mediated contraction, such as observed in trout, is unprecedented in mammalian smooth muscle. This suggests that H2S may have functions in nonmammalian vertebrates that are different from or in addition to its vasodilatory action in mammals. However, the physiological effects of H2S have not been examined in nonmammalian vertebrates, other than trout (7), and it has not been possible to determine whether the differences between trout and mammals reflect evolutionary trends, environmental constraints, or other factors.

The purpose of the present study was to examine the ubiquity of H2S as a vasoactive "gasotransmitter" in vertebrates and to provide initial insight into the factors that may have affected its physiological expression. To this end, we examined the response of systemic and, when possible, pulmonary arteries (PA) from each vertebrate class to H2S using in vitro myography. We found H2S-mediated vasoactivity in all vertebrate vessels; in many species, we found these responses to be vessel specific and often multiphasic.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals

All animal procedures received IACUC approval.

Pacific hagfish (Eptatretus stouti, 30–60 g) were captured off the coast of California and airlifted overnight to the University of Notre Dame (UND) in cold (5–8°C) seawater. The animals were housed at UND in 15-gallon saltwater aquaria at ~5°C and exposed to a 12:12-h light-dark photoperiod. They were not fed. Hagfish were anesthetized in benzocaine (1:5,000, wt/vol), and the dorsal aortas (DA) were dissected out and placed in hagfish buffered saline at 4°C until use.

Sea lampreys (Petromyzon marinus, 130–450 g) were trapped in streams feeding into the Great Lakes during the spring-summer spawning season and airlifted to UND where they were maintained in 500-liter rectangular tanks with aerated, flowing well water (15°C) and exposed to a 12:12-h light-dark photoperiod. They were not fed. Lampreys were anesthetized in benzocaine (1:5,000, wt/vol), and the DA were dissected out and placed in lamprey buffered saline at 4°C until use.

Sandbar sharks (Carcharhinus milberti) were captured off the Virginia coast by hook and line and held in captivity at the Virginia Institute of Marine Sciences for ~8 wk. They were then anesthetized with pentobarbital sodium (1–2 ml of a 390 mg/ml solution), and the DA, ventral aorta (VA), and afferent branchial arteries (ABA) were dissected out and placed in cold (4°C) elasmobranch buffered saline. The vessels were then airlifted overnight to UND and used within 24 h of arrival.

Marine toads (Bufo marinus) were purchased from a commercial supplier and maintained at Portland State University before shipment to UND. At UND, they were maintained under ~12:12-h light-dark cycles with ready access to water and were fed mealworms twice per week. The animals were anesthetized with benzocaine, and the aorta and PA were dissected out and placed in 4°C amphibian saline until use.

Female American alligators (Alligator mississippiensis, Reptilia) were maintained at the University of California-Irvine. They were anesthetized with 5% isofluorane and injected with 100 United States Pharmacopia units heparin/ml blood. Visceral organs were removed intact and shipped overnight in cold (4°C) saline to UND. On arrival, the aorta and PA were immediately removed and placed in cold reptilian saline until use.

Pekin ducks (Anas platyrhynchos domesticus, Aves) were obtained from a local abattoir. The birds were killed by cervical dislocation, and the visceral organs were immediately placed in cold (4°C) avian saline. At UND, the aorta and PA were removed and stored in cold avian saline until use.

White rats (Rattus rattus, Mammalia) were anesthetized with 50 mg/animal pentobarbital sodium, and the visceral organs were removed and placed in cold (4°C) Krebs-Henseleit mammalian saline. The aorta and PA were then dissected out and stored at 4°C until use. In a few experiments, rats were euthanized with CO2, and the vessels were removed as described above.

Smooth Muscle Isolation

The vessels were cut into 0.5- to 1.0-cm-long segments and mounted on 280-µm-diameter stainless steel wire hooks and suspended in 5-ml water-jacketed smooth muscle baths filled with the appropriate buffer at the animal's physiological temperature (hagfish: 14°C, lamprey: 14°C, shark: 23°C, toad: 25°C, alligator: 25°C, duck: 40°C, rat: 37°C). They were aerated with room air (HEPES buffers) or 95% air-5% CO2 (bicarbonate buffers). The bottom hooks were stationary; the upper ones were connected to Grass model FT03C force-displacement transducers (Grass Instruments, West Warwick, RI). Tension was measured on a Grass Instruments model 7E or 7F polygraph. Polygraph sensitivity was set to detect changes as small as 5 mg. We archived data on a personal computer at 1 Hz using Labtech notebook software (Laboratory Technologies, Andover, MA) or SoftWire (Measurement Computing, Middleboro, MA). The chart recorders and software were calibrated before each experiment.

Length-tension relationships have been derived from KCl-contracted vessels from most species in other studies (unpublished observations) in this laboratory. These data, plus general vessel size and physical characteristics, were taken into account to apply a reasonable baseline (resting) tension (~500–1,500 mg) for 0.5–1 h before experimentation. The vessels were then contracted with 80 mM KCl and washed twice, and resting tension was reestablished. The vessels were contracted a second time with 80 mM KCl and washed twice, and resting tension was reestablished for a minimum of 30 min before further experimentation. This procedure has been used to achieve optimum in vitro vessel activity (Olson, unpublished observations).

The cumulative dose-response characteristics of NaHS, which forms H2S in solution (45), were examined in otherwise unstimulated vessels and in vessels precontracted with another ligand. The ligands were selected for optimal contractile properties, i.e., for hagfish, 3 x 10–5 M carbachol; for lamprey, shark, and alligator, 10–6 M norepinephrine (NE); and for duck, 10–6 M arginine vasotocin (AVT). Vessels precontracted with NE were treated with 10–6 M propranolol 10 min before NE addition. Because of limited tissue availability, NaHS dose-response relationships were not obtained from precontracted marine toad aorta and PA and rat PA.

Data Analyses

We fit dose-response curves for each vessel using Table Curve (Jandel, Chicago, IL). In a few instances, the vessels were still responding at the highest NaHS concentrations (>10–2 M), and the EC50 was estimated. Student's t-tests were used for comparisons between groups of vessels (SigmaStat, Jandel). Results are expressed as means ± SD. Significance was assumed at P < 0.05.

Chemicals

Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO).

Physiological Salines

Hagfish HEPES-buffered saline. This saline solution (pH 7.8) contained (in mM) 474 NaCl, 8.05 KCl, 3.04 MgSO4 x 7H2O, 5.1 CaCl2 x 2H2O, 9 MgCl2 x 6H2O, 5.55 glucose, 3 HEPES acid, and 7 HEPES Na+ salt.

Lamprey and trout HEPES-buffered saline. This saline solution (pH 7.8) contained (in mM) 145 NaCl, 3 KCl, 0.57 MgSO4 x 7H2O, 2 CaCl2 x 2H2O, 5 glucose, 3 HEPES acid, and 7 HEPES Na+ salt.

Elasmobranch bicarbonate/phosphate-buffered saline. This saline solution (pH 7.6) contained (in mM) 280 NaCl, 6 KCl, 3 MgSO4 x 7H2O, 5 CaCl2 x 2H2O, 5 glucose, 0.5 Na2SO4, 1 NaH2PO4 x 2H2O, 8 NaHCO3, 350 urea, 72 trimethylamine-n-oxide, and 5 glucose.

Amphibian bicarbonate-buffered saline. This saline solution (pH 7.4) contained (in mM) 112 NaCl, 2 KCl, 1.8 CaCl2 x 2H2O, and 2.4 NaHCO3.

Reptilian bicarbonate-buffered saline. This saline solution (pH 7.8) contained (in mM) 80 NaCl, 2 CaCl2, 2.5 KCl, 1 MgCl2, 40 NaHCO3, and 10 glucose.

Avian bicarbonate/phosphate-buffered saline. This saline solution (pH 7.4) contained (in mM) 115 NaCl, 5 KCl, 0.5 MgCl2, 2.5 CaCl2 x 2H2O, 8.3 glucose, 0.8 NaH2PO4 x 2H2O, 10 NaHC3O2, 0.2 Na2HPO4, 25 NaHCO3, 5 alanine, and 0.11 ascorbic acid.

Mammalian Krebs-Henseleit bicarbonate-buffered saline. This saline solution (pH 7.4) contained (in mM) 115 NaCl, 2.51 KCl, 2.46 MgSO4, 1.91 CaCl2 x 2H2O, 5.56 glucose, 1.38 NaH2PO4 x 2H2O, and 25 NaHCO3.

All buffers were stored in the refrigerator and used within 72 h of preparation. The effects of NaHS on pH of the buffered salines were measured with a standard pH electrode at 22°C during step-wise addition of NaHS.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The effects of NaHS on unstimulated and precontracted vessels and their EC50 values are summarized in Tables 1 and 2, respectively. Figures 113 illustrate typical responses, and Fig. 14 is a cladogram of NaHS vasoactivity.


View this table:
[in this window]
[in a new window]
 
Table 1. Responses of otherwise unstimulated vessels to NaHS

 

View this table:
[in this window]
[in a new window]
 
Table 2. Responses of pre-contracted vessels to NaHS

 


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Typical records of the cumulative NaHS dose-response characteristics in both unstimulated (A) and 10–5 M carbachol (CARB)-precontracted (B) Pacific hagfish dorsal aorta (DA). Values indicate log M NaHS concentration ([NaHS]); unlabeled arrows represent 3x the previous [NaHS]. W, wash of agonists.

 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 13. NaHS dose-response curve for unstimulated rat thoracic aortas from animals euthanized with CO2 ({circ}) or pentobarbital (PB; {square}). EC50 values for CO2 and PB (5.96 ± 2.03 x 10–3 M, n = 7, and 1.34 ± 0.25 x 10–2 M, n = 8, respectively) are significantly (P < 0.05) different.

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 14. Cladogram illustrating the responses of systemic (symbols above thick line) and either pregill or pulmonary (symbols below line) vessels to NaHS. +, Contraction; –, relaxation. Groups of symbols represent multiphasic responses. Responses in parentheses indicate those observed only in precontracted vessels.

 
Pacific Hagfish DA

A few unstimulated hagfish DA displayed a small contraction at NaHS concentrations of <3 x 10–5 M; however, concentrations greater than this produced a predominant dose-dependent relaxation (Fig. 1). Vessels were still relaxing at 10–1 M NaHS, at which point the experiment was terminated. Carbachol-precontracted DA also contracted slightly at low (<3 x 10–5 M) NaHS concentrations and relaxed at higher concentrations. At ~10–3 M NaHS, nearly 100% of the carbachol-induced contraction was abolished. The vessels did not return to baseline tension after the NaHS was removed, and they were largely unresponsive to further carbachol or NaHS exposure.

Sea Lamprey DA

NaHS contracted otherwise unstimulated (Fig. 2) and NE-precontracted sea lamprey (not shown) DA with a threshold slightly above 10–5 M. In other experiments, a single application of 10–3 M NaHS to NE-contracted DA produced an initial steep contraction, followed by a delay (or slight relaxation), and then an even greater contraction (Fig. 3A). The vessels returned to baseline tension after removal of NaHS. When these vessels were contracted a second time with NE and exposed to 10–3 M NaHS, they developed a similar amount of total tension, but the initial contraction and relaxation were essentially lost (Fig. 3B).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. NaHS dose-response curve for unstimulated sea lamprey DA (n = 7). Inset: typical record. Values indicate log M [NaHS]; unlabeled arrows represent 3x the previous [NaHS].

 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Typical record of a 10–6 M norepinephrine (NE)-precontracted sea lamprey DA after an initial exposure to 10–3 M NaHS in which an initial transient contraction and possible relaxation are observed (A); this was followed by a wash and then a second NaHS exposure (B), which eliminated all but the last phase. Prop, propranolol.

 
Sandbar Shark DA, VA, and ABA

All unstimulated shark vessels, including spontaneously contracting DA, displayed a threshold relaxation at 3 x 10–4 M NaHS (Fig. 4). This did not appear to be dose dependent because further increases in NaHS concentration did not affect vessel tension.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4. Typical records of the cumulative NaHS dose-response characteristics of an unstimulated afferent branchial artery (ABA), ventral aorta (VA), and DA from the sandbar shark. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS]. Large arrows at the end of the records (W) represent 2 consecutive washes. Entire response occurs at essentially 3 x 10–4 M NaHS.

 
As has been shown in other elasmobranchs (27), precontraction often increases the baseline tension as well as frequency and amplitude of spontaneous contractions. These parameters in spontaneously active DA and ABA were inhibited with NaHS at the same 3 x 10–4 M threshold (Fig. 5). Conversely, most VA displayed little response to NE stimulation or NaHS, although removal of NE and NaHS produced several large transient contractions (Fig. 5). A few additional differences between DA and ABA were noted. The spontaneous contractions of NE-precontracted ABA had greater amplitude and lower frequency than those observed in DA (Fig. 5). In ABA, 3 x 10–4 M NaHS nearly eliminated the spontaneous contractions, but in the remaining few contractions the amplitude was not appreciably affected. In precontracted DA, both the amplitude and baseline tension were greatly reduced by NaHS; however, the frequency was largely unaffected. The spontaneous contractions often returned after both NaHS and NE were removed, suggesting that the vessels recovered faster from the NaHS than from NE.



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5. Typical tracings of the cumulative NaHS dose-response characteristics of a 10–6 M NE-precontracted ABA, VA, and DA from the sandbar shark. Vessels were pretreated with 10–5 M Prop before NE. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS]. Large arrows at the end of the records (W) represent 2 consecutive washes. The NE precontraction produced spontaneous contractions in ABA and DA, which were inhibited by a threshold dose of 3 x 10–4 M NaHS. The frequency of spontaneous contractions in ABA also appeared to be increased by 3 x 10–5 M NaHS.

 
Marine Toad Aorta and PA

NaHS produced essentially identical dose-dependent monophasic contractions of both unstimulated (Fig. 6, top) and NE-precontracted marine toad aorta with a threshold concentration of 3 x 10–4 M. The strongest contraction was produced at the highest dose used (10–2 M NaHS), and it was difficult to establish an accurate EC50. At this dose (10–2 M), considerable tension was produced in otherwise unstimulated vessels, >1 g of tension/10 mg vessel wet wt. The vessels did not recover after NaHS washout, and their response to KCl was reduced by over 90%.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6. Typical tracings of the cumulative NaHS dose-response characteristics of unstimulated thoracic aorta (top) and pulmonary arteries (PA; bottom) from the marine toad. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS]. The aortic response was monophasic, whereas PA responses were multiphasic, dominated by a contraction at low doses (10–4 M), a slight contraction and then relaxation at 10–3 M, and slight contraction-relaxation and then dominant contraction at 10–2 M.

 
The responses of both unstimulated (Fig. 6, bottom) and NE-precontracted PA appeared multiphasic. At low doses (10–4 M NaHS), there was a monophasic contraction that changed to a transient contraction superseded by relaxation at 10–3 M. At 3 x 10–3 M, only a relaxation was observed, whereas at 10–2 M NaHS, there was a transient contraction, relaxation, and then a sustained contraction. The vessels did not recover after NaHS removal. We could only obtain a total of four PA from two animals, and, because these vessels were small (~3 mg), as was the magnitude of the response, the dose-response characteristics of the individual phases in precontracted vessels could not be determined.

American Alligator Aorta and PA

Unstimulated American alligator AP and PA displayed dose-dependent contraction to NaHS (Fig. 7). The vessels were still contracting significantly at the highest dose examined (10–1 M), and EC50 values were estimated. Aortas and PA precontracted with 10–6 M NE also displayed a similar NaHS dose-dependent contraction (data not shown). In other experiments on NE-precontracted vessels, a single treatment with 10–3 M NaHS produced a contraction in aortas that was of similar magnitude to the NE contraction, whereas the PA response to NaHS was fourfold greater than the NE contraction (Fig. 8).



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 7. Typical tracings of the cumulative NaHS dose-dependent contractions of unstimulated thoracic aorta (top) and PA (bottom) from the American alligator. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS].

 


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 8. Tracings showing the relative efficacy of 10–5 M NE and 10–3 M NaHS on the NE contraction in thoracic aorta (top) and PA (bottom) from the American alligator. NaHS is clearly a better agonist in PA than in the aorta.

 
Pekin Duck Aorta and PA

NaHS produced a dose-dependent contraction in unstimulated duck thoracic aorta with a threshold around 10–4 M (Fig. 9). The EC50 values were estimated because aortas were still responding at the highest dose (10–2 M); however, the vessels recovered when NaHS was removed. Aortas precontracted with 10–6 M AVT displayed a brief and small relaxation to 3 x 10–5 M NaHS, but subsequent doses resulted in contraction on top of the AVT plateau (Fig. 10). To examine whether this relaxation was a single event or dependent on the NaHS concentration, another group of aortas were precontracted with 10–6 M AVT or 80 mM KCl, and doses exceeding 3 x 10–5 M NaHS were applied. Invariably, if NaHS concentration was >3 x 10–5 M, it produced a contraction (not shown).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 9. NaHS dose-dependent responses of unstimulated thoracic aorta (top) and PA (bottom) from the Pekin duck. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS]. Aortic responses are monophasic; PA show a transient contraction and then relaxation at lower [NaHS] that gives way to a contraction and then triphasic contraction-relaxation-contraction at high (10–2 M) NaHS.

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 10. Traces of the cumulative NaHS dose-response characteristics of 10–6 M arginine vasotocin (AVT)-precontracted thoracic aorta (top) and PA (bottom) from the Pekin duck. Values indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS]. NaHS produced a monophasic contraction of aortas, except for a slight relaxation at the lowest dose. Low doses of NaHS produced a dose-dependent relaxation of PA, which was replaced by contraction at higher doses.

 
NaHS produced multiphasic responses in unstimulated PA (Fig. 9). At low (~10–5 M) concentrations, NaHS was mainly contractile. At 10–4 M, a brief contraction was followed by relaxation and a small contraction, and, at 3 x 10–4 M, the initial brief contraction was followed by a sustained relaxation. NaHS concentrations of 10–3 and 3 x 10–3 M produced monophasic contractions, and the triphasic response reappeared at 10–2 M NaHS. Spontaneous contractions appeared in AVT-precontracted PA, and, although they were inhibited by NaHS, it was not possible to examine NaHS effects at low (<10–4 M) concentrations. Higher concentrations of NaHS produced a triphasic contraction-relaxation-contraction (from 10–4 to 3 x 10–4 M) and a monophasic contraction at NaHS in excess of 10–3 M NaHS. Both unstimulated and AVT-precontracted vessels completely recovered when the compounds were washed out.

The dose-response curves for phase 2 relaxation and phase 3 contraction of unstimulated and precontracted PA are shown in Fig. 11. The predominant dose-dependent relaxation at lower NaHS concentrations may in fact be masking a portion of the dose-dependent constriction, or there may be two distinct contractile responses.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 11. Cumulative dose-response curves for the contraction (squares) and relaxation (circles) of unstimulated (open symbols) and AVT-precontracted (solid symbols) duck PA. EC50 values for unstimulated and AVT-precontracted relaxation were 8.86 ± 3.19 x 10–5 M (n = 8) and 4.73 ± 3.10 x 10–5 M NaHS (n = 8), respectively. EC50 values for unstimulated and AVT-precontracted contraction were 2.34 ± 1.19 x 10–3 M (n = 8) and 1.78 ± 0.99 x 10–3 M NaHS (n = 8), respectively. SD omitted for clarity.

 
Rat Thoracic Aorta

Unstimulated rat thoracic aortas displayed little activity to NaHS until doses were elevated to 10–3 M, and monophasic contractions were observed thereafter (Fig. 12). The method of euthanasia appeared to affect the vessel's response, as the EC50 for aorta from rats euthanized with CO2 was significantly (P < 0.05) lower than for rats euthanized with pentobarbital (Fig. 13). NaHS produced a dose-dependent relaxation of aorta precontracted with 10–7 NE (not shown).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 12. Typical record of the monophasic, dose-dependent contractile response of unstimulated rat aorta to NaHS and the triphasic response (in parentheses) of 10–6 M NE-precontracted rat PA to 10–3 M NaHS. Values for aorta indicate log [NaHS]; unlabeled arrows represent 3x the previous [NaHS].

 
Rat PA precontracted with 10–7 NE displayed a triphasic contraction-relaxation-contraction when exposed to 10–3 M NaHS (n = 7, Fig. 12). No other studies have been performed on rat pulmonary vessels.


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The results from the present study show that H2S has vasoactive properties in at least one species from each class of vertebrates; results also support the hypothesis that this gasotransmitter is a phylogenetically ancient vasoregulatory molecule. However, unlike the monophasic vasorelaxation that has been reported previously in the rat (45, 47) our studies show that H2S has both vasodilatory and vasoconstrictory properties. Furthermore, these disparate responses may occur in different vascular beds within a single species or even in the same vessel at different levels of H2S exposure. This level of complexity and versatility suggests that H2S may be unparalleled as a vasoregulatory molecule and that it may have been opportunistically adapted to suit diverse homeostatic functions.

It is difficult to unequivocally establish evolutionary patterns or environmental factors that may have been involved in the determination of H2S vasoactivity because of the variety of H2S-mediated responses and the fact that we only examined a single species from each class of vertebrates. However, there are some interesting points that deserve discussion and certainly further investigation.

Antiquity of the H2S Response

H2S joins NO as the second putative gasotransmitter with demonstrated vasoactivity in all nonmammalian vertebrates examined to date, but this is not proof that they are endogenous vasoregulators. There is still considerable controversy regarding whether NO is produced by fish vascular endothelium and whether it acts as a local messenger. NO, or NO donors such as SNP, are vasoconstrictors in Agnathans and Chondrichthyes (8, 10) and vasodilators in Osteichthyes (6, 10, 12, 19, 22, 28, 30, 32, 35, 36). However, although studies in vivo or in perfused organ preparations have supported NO as an endothelium-derived dilator in Osteichthyes (12, 17, 23, 32, 37), studies on isolated blood vessels have failed to support an endothelial source of NO from any fish (9, 11, 19, 28), and the possibility remains that NO signaling from the vascular endothelium originated in Amphibia (22).

Information regarding vascular H2S production is limited, although there is support for H2S as a vascular signaling molecule in Osteichthyes. In preliminary studies, our laboratory found that rainbow trout vessels produce H2S (26) and that H2S circulates in the plasma at physiologically relevant levels (7). Although additional studies on Agnatha and Chondrichthyes are needed, it is possible that H2S predates NO as an endogenous vasoregulatory gasotransmitter.

The "Primordial" Response

With the exception of Chondrichthyes, we found that H2S has some contractile activity in all vertebrates (Fig. 14), which suggests that vasoconstriction may be the most phylogenetically ancient and prevalent response. Earlier reports of the effects of H2S on precontracted rat aortas indicated a monophasic, dose-dependent relaxation, without any contraction (16, 45, 47). However, as shown in Fig. 12, H2S produces essentially a monophasic contraction in unstimulated rat aortas, and the threshold for this contraction, 3 x 10–3 M (Fig. 12), is 15-fold greater than the threshold for relaxation of precontracted aortas (45, 47). A substantial contraction is also evident in NE-precontracted rat PA exposed to 10–3 M H2S (Fig. 12).

The weakest contractile response of nonmammalian vertebrates was observed in hagfish aortas (Fig. 1), and no contraction was observed in shark aortas. Unlike the rat aorta, H2S-mediated relaxations in the hagfish and shark were independent of prestimulation. The latter two were also the only two marine vertebrates examined and the only two with plasma osmolarity above 350 mosM. It remains to be determined whether there is an environmental correlate with H2S vasoactivity. A similar case for an environmental component could be made for the aortas of terrestrial vertebrates, all of which contract when exposed to H2S, in the absence of a precontraction, and all but the rat contract in the presence of precontractile stimulation. The shark response was also unique in that it occurred at a single threshold dose. It is possible that a dose-dependent response falls between the doses used (10–4 and 3 x 10–4 M H2S), although this seems unlikely. One could also argue that relaxation and constriction may have appeared nearly simultaneously during vertebrate evolution because the responses of the two Agnathans used in this study were essentially the opposite. In addition, multiphasic responses were observed in all but two of the vertebrates (Fig. 14).

Tissue Specificity and Multiphasic Responses

A striking finding of this study is the dissimilarity between the H2S responses of systemic and respiratory vessels in trout, toads, birds, and mammals. In all but the trout, the aortic responses were monophasic and pulmonary responses were triphasic and consistently a contraction-relaxation-contraction. Even in the alligator, where H2S contracted both systemic and pulmonary vessels, H2S was considerably more potent in the latter (Fig. 8) and the threshold was 10-fold lower. The general differences between H2S responses in systemic and respiratory vessels strongly suggest that H2S performs tissue-specific functions and that it is more versatile in the systemic circulation of trout and the pulmonary circulation of most terrestrial vertebrates.

The multiphasic response itself is both unusual and versatile. It is technically difficult to separate all three phases and to identify the dose dependency of each. However, we (7) have previously characterized the second (constriction) and third (dilation) phases in trout efferent branchial arteries and found that there is only a 16-fold difference in the EC50 between the two phases. Although we can only estimate the EC50 values for the third (contraction) phase of the toad and duck, the difference in otherwise unstimulated toad PA is only 3-fold and in unstimulated and precontracted duck PA the difference is 26- and 38-fold, respectively. These estimates can be refined and extended to other vertebrates once specific inhibitors of the different phases are identified; nevertheless, they strongly suggest that the outcome of H2S vasoactivity can be readily reversed with modest adjustments in either H2S production or inactivation.

Physiological Relevance of H2S Doses

Plasma H2S concentrations in trout and rats are between 4 x 10–5 and 3 x 10–4 M (7, 43, 44, 47), and because H2S is synthesized by vascular smooth muscle it is likely that tissue levels exceed those in the plasma. To our knowledge, plasma H2S concentrations have not been reported for any other vertebrate, but they are probably similar to the trout and rat. Nearly all of the vessels that we examined responded to these physiologically relevant H2S levels, and we assume that this is indicative of a tonic vasoregulatory activity of H2S. We also observed substantial vasoactivity at higher H2S concentrations, but the physiological relevancy of this will not be known until intravascular and intracellular H2S concentrations have been determined.

Potential Sources of Variability/Error

Although we feel that the responses to NaHS observed in the present study are typical for an individual species, there are a number of factors that could contribute to some variability in the pattern of response or the sensitivity of the vessel. Some of these factors are methodological, such as the variety of euthanasia methods and incubation media used and/or delays incurred during shipping and storage. Other variability could be attributable to indirect effects that H2S might have on extracellular pH (pHo) and intracellular pH (pHi), PO2, and H2S toxicity. These points are briefly considered in the following paragraphs.

Method of euthanasia. The variety of anesthetics used during euthanasia could contribute to variability in the H2S response, although we believe that the differences, if present, may be more in terms of H2S sensitivity rather than substantiative changes in the overall response pattern. In previous studies (7, and Dombkowski, Russell, and Olson, unpublished observations), we observed a similar triphasic H2S response in efferent branchial arteries from steelhead trout anesthetized with ethyl-m-aminobenzoate (MS-222) and from rainbow trout (both O. mykiss) killed by a blow to the head. However, there were slight differences between these two strains in the dependence of phase 2 contraction on extracellular calcium, and it is not known whether this is characteristic of the different strains of trout or the effect of MS-222. An anesthetic effect is apparent in the H2S-mediated contraction of unstimulated aortas from carbon dioxide- vs. pentobarbital sodium-euthanized rats (Table 1), where the former appears twice as sensitive to H2S. Nevertheless, H2S produced a monophasic contraction in both groups, whereas H2S consistently relaxed precontracted aortas (47) from rats also killed after pentobarbital sodium anesthesia (Wang, personal communication). Duck vessels were not exposed to any anesthetic, yet they exhibited vessel-specific and, in the case of pulmonary vessels, multiphasic responses to NaHS. Thus it seems unlikely that anesthetics affect the general NaHS response.

Vessel storage. It has been our experience that vessels stored in cold physiological buffers remain viable and fully responsive to a variety of agonists for several days and vessels from ectothermic vertebrates even longer. Because vessels from both endothermic vertebrates were used within 24 h, little, if any, degradation in H2S response is expected.

Buffer characteristics. A variety of salines and buffers was used in the present studies for several reasons: they were used in the laboratory that supplied the tissue, they were commonly cited in the literature, and, in the case of the HEPES buffers, they were specifically developed in this laboratory for use with isolated fish vessels. However, these salines could affect the vessel's response, either because the chemical composition was not ideal or because the buffering capacity was insufficient at elevated NaHS concentrations. Although it is beyond the scope of this study to attempt to optimize the salines, the effects of NaHS and H2S on pHo and pHi and the potential for pH-mediated effects on vascular tone need consideration.

NaHS could potentially affect both pHo and pHi. In the medium, formation of HS from the dissociation of NaHS to Na+ + HS and subsequent formation of H2S would be expected to raise pHo, whereas the gaseous H2S, after rapidly diffusing into the cell and dissociating into H+ and HS, would paradoxically lower pHi. The degree of change in either pHo or pHi depends of course on the buffering capacity of the respective environments.

The effects of a wide range of NaHS concentrations on buffer pH is shown in Fig. 15. The pH of all media was relatively stable until NaHS concentrations exceed 1 mM. At 1 mM, pH of most salines increased by 0.1 pH unit or less; even at 10 mM NaHS, most salines maintained pH within ~0.5 of the initial value. The amphibian and elasmobranch salines were the least effective, and 10 mM NaHS increased pH by nearly two units in the former and almost one unit in the latter. The effects of NaHS on pHi are beyond the scope of this study; however, as described below, they may not mirror changes in pHo.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 15. Effect of NaHS on pH of physiological salines used in this study.

 
In mammalian vessels, alkalinization of either extracellular or intracellular milieu generally produces contraction and acidification produces relaxation (2). The variety of NaHS responses observed in this study suggests that either 1) different vessels react differently to a common change in pH, 2) NaHS has variable effects on pHo and pHi in different vessels and/or media, or 3) pH is not a major mediator of the NaHS response. Sorting out these possibilities will be difficult because even the response of nonmammalian vessels to pH remains unclear. However, several points favor the third option. First, pHo remains relatively constant until NaHS exceeds 1 mM; therefore, contractions at lower NaHS concentrations are unlikely pH mediated. Second, NaHS-mediated relaxations are not due to a change in pHo because NaHS only alkalinizes the medium. Third, only a fraction (<25%; Ref. 7) of the dissolved NaHS exists as H2S at physiological pH; therefore, the effects of NaHS on intracellular H2S and pHi would be expected to be less than the effects on pHo. Furthermore, as pH increases, the H2S fraction decreases. For example, at 20°C, the pKa is nearly 7 (5, 26), and, if pH is 7.5, then a solution of NaHS is nearly 25% H2S. If pH increases to 8.5, then only 3% of the dissolved NaHS is H2S; this falls to 1% at pH 9. Experimentally, Jacques (18) has shown that H2S entry into cells of the marine alga, Valonia macrophysa, decreases by 80% as ambient alkalinity increases from a pH of 7.04 to 8.20. This creates an interesting dichotomy; buffers such as HEPES are better at preventing an increase in pHo but are predicted to favor a decrease in pHi. Thus, on the basis of pH changes alone, vessels in well-buffered media would be predicted to relax at high NaHS concentrations due to the fall in pHi, whereas, in poorly buffered media, the rise in pHo at elevated NaHS concentrations should favor contraction. There was no consistent trend to support this hypothesis in the present experiments, suggesting that, although some of the NaHS vasoactivity may be due to pH effects, a change in pH per se is not a major mechanism of NaHS action in vertebrate vessels. This also suggests that the lower EC50 for contractions observed in aortas from rats euthanized with CO2 was not a residual effect of hypercapnic acidosis, as this would be predicted to decrease a NaHS contraction. A residual effect of CO2 on other cellular processes appears more likely.

H2S oxidation-O2 reduction. Oxidation of H2S by ambient or intracellular oxygen can potentially lower H2S levels and bias H2S dose-response estimates. Determination of intracellular H2S concentration is further complicated by the pH-dependent equilibrium of H2S across cell membranes (described above) and by tissue production of H2S (14, 16, 43, 46, 47). Thus the actual sensitivity of tissues to H2S may be either lower or greater than published values.

Conversely, reduction of tissue oxygen by H2S could produce hypoxia, which in itself could be vasoactive. Although spontaneous oxidation of H2S in the presence of O2 is rather slow (the half-time is in the order of 0.4 to 65 h in air-saturated seawater), catalyzed oxidation in cells is undoubtedly faster (3). With the oxygen solubility coefficient ranging between 1.25 and 2 µmol·l–1·Torr–1 at 37 and 10°C, respectively (4), oxygen and H2S would be present in approximately equimolar amounts at a tissue PO2 of 20 Torr. Even if PO2 was greater, addition of exogenous H2S could produce hypoxic conditions. In mammals, hypoxia generally relaxes systemic vessels and contracts pulmonary vessels (42). Hypoxia also contracts DA of both hagfish and lamprey (29). Although in some tissues the vasoactive effects of H2S and hypoxia were similar (for example, the precontracted rat aorta and lamprey DA), in many other vessels they were the opposite (hagfish, toad, alligator, duck, and unstimulated rat aortas). A H2S-induced hypoxia cannot be ruled out in vessels that displayed multiphasic responses; however, like pH, the hypoxic component of H2S vasoactivity appears to be secondary in many vessels.

H2S toxicity. Toxic effects of H2S have been attributed to the ability of H2S to inhibit cytochrome-c oxidase at low micromolar concentrations and to open the mitochondrial permeability transition pore at half-millimolar H2S concentrations (20, 24, 39, 40). The H2S concentration that inhibits cytochrome-c oxidase is well below the doses we used, but they are also lower than plasma levels in both trout and rats. Mitochondrial oxidation of H2S in intact tissues raises the toxic threshold two to three orders of magnitude above that of tissue homogenates or purified enzyme; in fact, mitochondria of some fish can use up to 20 µM sulfide for ATP production (3). Our experiments indicate that some vascular smooth muscle is also quite resistant to elevated H2S, as many vessels appeared to completely recover from exposure to millimolar levels of H2S. How this is accomplished is not known, but it does not appear to be due to adaptation of cytochrome-c oxidase because the enzyme is equally H2S sensitive in both H2S-sensitive and H2S-tolerant organisms (3). Furthermore, the lack of correlation between H2S-mediated and hypoxia-mediated vascular responses (see above) suggests that cytochrome-c oxidase is not inhibited in those blood vessels tolerant to high H2S concentrations. It remains to be determined how H2S protection is conveyed.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported in part by National Science Foundation Grant IBN 0235223.


    ACKNOWLEDGMENTS
 
The authors are indebted to the following for assistance in obtaining tissues: Drs. R. Brill, J. Hicks, S. Hillman, E. McKee, S. Munns, M. Suckow, and B. Swink and to B. Culver, E. Kisfaludy, and D. Meunick, and K. Stewart.


    FOOTNOTES
 

Address for reprint requests and other correspondence: K. R. Olson, South Bend Center for Medical Education, B-19 Haggar Hall, Univ. of Notre Dame, Notre Dame, IN 46556 (E-mail: kolson{at}nd.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Abe K and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066–1071, 1996.[Abstract/Free Full Text]
  2. Austin C and Wray S. Interactions between Ca2+ and H+ and functional consequences in vascular smooth muscle. Circ Res 86: 355–363, 2000.[Abstract/Free Full Text]
  3. Bagarinao T. Sulfide as an environmental factor and toxicant: tolerance and adaptations in aquatic organisms. Aquat Toxicol (Amst) 24: 21–62, 1992.[CrossRef]
  4. Boutilier RG, Heming TA, and Iwama GK. Physiochemical parameters for use in fish respiratory physiology. In: Gills. Fish Physiology, edited by Hoar WS and Randall DJ. Orlando, FL: Academic, 1984, vol. X, part A, p. 401–430.
  5. Broderius SJ and Smith LL. Direct determination and calculation of aqueous hydrogen sulfide. Anal Chem 49:424–28, 1977.
  6. Conklin DJ and Olson KR. Compliance and smooth muscle reactivity of rainbow trout (Oncorhynchus mykiss) vessels in vitro. J Comp Physiol [A] 163: 657–663, 1994.
  7. Dombkowski RA, Russell MJ, and Olson KR. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286: R678–R685, 2004.[Abstract/Free Full Text]
  8. Evans DH. Vasoactive receptors in abdominal blood vessels of the dogfish shark, Squalus acanthias. Physiol Biochem Zool 74: 120–126, 2001.[CrossRef][ISI][Medline]
  9. Evans DH and Gunderson MP. A prostaglandin, not NO, mediates endothelium-dependent dilation in ventral aorta of shark (Squalus acanthias). Am J Physiol Regul Integr Comp Physiol 274: R1050–R1057, 1998.[Abstract/Free Full Text]
  10. Evans DH and Harrie AC. Vasoactivity of the ventral aorta of the American eel (Anguilla rostrata), Atlantic hagfish (Myxine glutinosa), and sea lamprey (Petromyzon marinus). J Exp Zool 289: 273–284, 2001.[CrossRef][ISI][Medline]
  11. Farrell AP and Johansen JA. Vasoactivity of the coronary artery of rainbow trout, steelhead trout, and dogfish: lack of support for non-prostanoid endothelium-derived relaxation factors. Can J Zool 73: 1899–1911, 1995.
  12. Fritsche R, Schwerte T, and Pelster B. Nitric oxide and vascular reactivity in developing zebrafish, Danio rerio. Am J Physiol Regul Integr Comp Physiol 279: R2200–R2207, 2000.[Abstract/Free Full Text]
  13. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle cells by acetylcholine. Nature 288: 373–376, 1980.[CrossRef][Medline]
  14. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, and Tang C. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313: 362–368, 2004.[CrossRef][ISI][Medline]
  15. Guidotti TL. Hydrogen sulphide. Occup Med 46: 367–371, 1996.[Abstract/Free Full Text]
  16. Hosoki R, Matsuki N, and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527–531, 1997.[CrossRef][ISI][Medline]
  17. Hylland P and Nilsson GE. Evidence that acetylcholine mediates increased cerebral blood flow velocity in crucian carp through a nitric oxide-dependent mechanism. J Cereb Blood Flow Metab 15: 519–524, 1995.[ISI][Medline]
  18. Jacques AG. The kinetics of penetration. XII. Hydrogen sulfide. J Gen Physiol 19: 397–418, 1936.[Abstract/Free Full Text]
  19. Jennings BL, Broughton BR, and Donald JA. Nitric oxide control of the dorsal aorta and the intestinal vein of the Australian short-finned eel Anguilla australis. J Exp Biol 207: 1295–1303, 2004.[Abstract/Free Full Text]
  20. Khan AA, Schuler MM, Prior MG, Yong S, Coppock RW, Florence LZ, and Lillie LE. Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats. Toxicol Appl Pharmacol 103: 482–490, 1990.[CrossRef][ISI][Medline]
  21. Lin H and McGrath JJ. Vasodilating effects of carbon monoxide. Drug Chem Toxicol 11: 371–385, 1988.[ISI][Medline]
  22. Miller VM and Vanhoutte PM. Endothelium-dependent responses in isolated blood vessels of lower vertebrates. Blood Vessels 23: 225–235, 1986.[ISI][Medline]
  23. Mustafa T and Agnisola C. Vasactivity of adenosine in the trout (Oncorhynchus mykiss) coronary system: involvement of nitric oxide and interaction with noradrenaline. J Exp Biol 201: 3075–3083, 1998.[Abstract]
  24. Nicholls P and Kim JK. Sulphide as an inhibitor and electron donor for the cytochrome oxidase system. Can J Biochem 60: 613–623, 1982.[ISI][Medline]
  25. Nicholson RA, Roth SH, Zhang A, Zheng J, Brookes J, Skrajny B, and Bennington R. Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain. J Toxicol Environ Health 54: 491–507, 1988.[CrossRef]
  26. Olson KR. Vascular actions of hydrogen sulfide in nonmammalian vertebrates. Antioxid Redox Signal In press.
  27. Olson KR, Conklin DJ, Farrell AP, Keen JE, Takei Y, Weaver L, Smith MP, and Zhang Y. Effects of natriuretic peptides and nitroprusside on venous function in trout. Am J Physiol Regul Integr Comp Physiol 273: R527–R539, 1997.[Abstract/Free Full Text]
  28. Olson KR, Forster ME, Bushnell PG, and Duff DW. Spontaneous contractions in elasmobranch vessels in vitro. J Exp Zool 286: 606–614, 2000.[CrossRef][ISI][Medline]
  29. Olson KR, Russell MJ, and Forster ME. Hypoxic vasoconstriction of cyclostome systemic vessels: the physiological antecedent of hypoxic pulmonary vasoconstriction? Am J Physiol Regul Integr Comp Physiol 280: R198–R206, 2001.[Abstract/Free Full Text]
  30. Olson KR and Villa J. Evidence against non-prostanoid endothelial-derived relaxing factor(s) in trout vessels. Am J Physiol Regul Integr Comp Physiol 260: R925–R933, 1991.[Abstract/Free Full Text]
  31. Reiffenstein RJ, Hulbert WC, and Roth SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 32: 109–134, 1992.[CrossRef][Medline]
  32. Schwerte T, Holmgren S, and Pelster B. Vasodilation of swimbladder vessels in the European eel (Anguilla anguilla) induced by vasoactive intestinal peptide, nitric oxide, adenosine and protons. J Exp Biol 202: 1005–1013, 1999.[Abstract]
  33. Shi L, Du J, Qi J, Wei B, Tang C, and Tang X. Effects of high pulmonary blood flow on pulmonary vasculature structure and the gene expression of cystathionine-{gamma}-lyase. Beijing Da Xue Xue Bao 35: 566–570, 2003.[Medline]
  34. Sidhu R, Sing M, Samir G, and Carson RJ. L-Cysteine and sodium hydrosulphite inhibit spontaneous contractility of isolated pregnant rat uterine strips in vitro. Pharmacol Toxicol 88: 198–203, 2001.[CrossRef][ISI][Medline]
  35. Small SA, MacDonald C, and Farrell AP. Vascular reactivity of the coronary artery in rainbow trout (Oncorhynchus mykiss). Am J Physiol Regul Integr Comp Physiol 258: R1402–R1410, 1990.[Abstract/Free Full Text]
  36. Smith MP, Takei Y, and Olson KR. Similarity of vasorelaxant effects of natriuretic peptides in isolated blood vessels of salmonids. Physiol Biochem Zool 73: 494–500, 2000.[CrossRef][ISI][Medline]
  37. Söderström V, Hylland P, and Nilsson GE. Nitric oxide synthase inhibitor blocks acetylcholine induced increase in brain blood flow in rainbow trout. Neurosci Lett 197: 191–194, 1995.[CrossRef][ISI][Medline]
  38. Teague B, Asiedu S, and Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 137: 139–145, 2002.[CrossRef][ISI][Medline]
  39. Thompson RW, Valentine HL, and Valentine WM. Cytotoxic mechanisms of hydrosulfide anion and cyanide anion in primary rat hepatocyte cultures. Toxicology 188: 149–159, 2003.[ISI][Medline]
  40. Torrans EL and Clemens HP. Physiological and biochemical effects of acute exposure of fish to hydrogen sulfide. Comp Biochem Physiol 71C: 183–190, 1982.
  41. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792–1798, 2002.[Abstract/Free Full Text]
  42. Weir EK, Reeve SL, Cornfield DN, Tristani-Firouzi M, Peterson DA, and Archer SL. Diversity of response in vascular smooth muscle cells to changes in oxygen tension. Kidney Int 51: 462–466, 1997.[ISI][Medline]
  43. Yan H, Do J, and Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313: 22–27, 2004.[CrossRef][ISI][Medline]
  44. Zhang C, Du J, Bu D, Yan H, Tang X, and Tang C. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302: 810–816, 2003.[CrossRef][ISI][Medline]
  45. Zhao W and Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474–H480, 2002.[Abstract/Free Full Text]
  46. Zhao W, Ndisang JF, and Wang R. Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol 81:848–53, 2003.[CrossRef][ISI][Medline]
  47. Zhao W, Zhang J, Lu Y, and Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008–6016, 2001.[CrossRef][ISI][Medline]
  48. Zhong G, Chen F, Cheng Y, Tang C, and Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1897–1885, 2003.[CrossRef][ISI][Medline]



This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
K. R. Olson
Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control
J. Exp. Biol., September 1, 2008; 211(17): 2727 - 2734.
[Abstract] [Full Text] [PDF]